Epilepsy, Generalized clinical trials

The registry lists 39 studies for Epilepsy, Generalized across more than 10 countries. 4 are recruiting or about to start. 17 of them are mainly about Epilepsy, Generalized (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-28. Counting its 5 narrower conditions too, such as Epilepsies, Myoclonic: 239 studies, 38 open.

Get an email when these change. Save the Epilepsy, Generalized studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 30
Recruiting: 3
Terminated: 2
Status unknown: 2
Not yet recruiting: 1
Withdrawn: 1

Phase

Phase 3: 12
Phase 2: 4
Phase 4: 3

Where

United States: 14
France: 4
Australia: 2
India: 2
China: 1
Netherlands: 1

Who runs them

UCB Pharma (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · Lundbeck LLC (2) · Oslo University Hospital (1) · Oregon Health and Science University (1) · Arak University of Medical Sciences (1) · UCB Pharma SA (1) · Second Affiliated Hospital, School of Medicine, Zhejiang University (1)

What is being tested here

Drugs under test in Epilepsy, Generalized studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Cenobamate	1	1	1
Levetiracetam	0	4	4
Topiramate	0	2	3
Clobazam	0	1	2
NPT 2042	0	0	1
Melatonin	0	0	1
Diazepam	0	1	1
Opakalim	0	1	1

Drug classes tested here Anxiolytics 3

Coming up

1phase 3 study under way

3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Jan 2027ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures. · Phase 3 · Ono Pharmaceutical Co. Ltd
May 2027Baker Gordon Syndrome Natural History Study · University of Missouri-Columbia
Jun 2027Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy · University of California, San Francisco

Who these studies take

Of the 3 Epilepsy, Generalized studies recruiting now, 1 (33%) set no upper age limit and 1 (33%) stop at 75 or younger. 2 (67%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 3
Age	Women	Men
10	1 (33%)	1 (33%)
18	2 (67%)	2 (67%)
30	3 (100%)	3 (100%)
40	3 (100%)	3 (100%)
50	3 (100%)	3 (100%)
65	3 (100%)	3 (100%)
75	2 (67%)	2 (67%)
85	2 (67%)	2 (67%)

Across all 39 studies, recruiting or not: 46% stop at 75 or younger and 38% at 65; 67% take children; 0% are for women only and 0% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 39 of 39. search them.